A síndrome de imunodisregulação - poliendocrinopatia - enteropatia - ligada ao X (IPEX) é uma doença autoimune sistêmica congênita grave caracterizada por diarreia refratária, endocrinopatias, envolvimento cutâneo e infecções.
Introdução
O que você precisa saber de cara
A síndrome de imunodisregulação - poliendocrinopatia - enteropatia - ligada ao X (IPEX) é uma doença autoimune sistêmica congênita grave caracterizada por diarreia refratária, endocrinopatias, envolvimento cutâneo e infecções.
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 24 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 79 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição. Padrão de herança: X-linked recessive.
Transcriptional regulator which is crucial for the development and inhibitory function of regulatory T-cells (Treg) (PubMed:17377532, PubMed:21458306, PubMed:23947341, PubMed:24354325, PubMed:24722479, PubMed:24835996, PubMed:30513302, PubMed:32644293). Plays an essential role in maintaining homeostasis of the immune system by allowing the acquisition of full suppressive function and stability of the Treg lineage, and by directly modulating the expansion and function of conventional T-cells (Pub
NucleusCytoplasm
Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome
Characterized by neonatal onset insulin-dependent diabetes mellitus, infections, secretory diarrhea, thrombocytopenia, anemia and eczema. It is usually lethal in infancy.
Variantes genéticas (ClinVar)
236 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
2 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
Publicações mais relevantes
Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.
Immunodysregulation, Polyendocrinopathy, Enteropathy, and X-linked (IPEX) syndrome is a rare autoimmune disorder caused by mutations in the FOXP3 gene. Patients with IPEX frequently present with severe dermatitis, diabetes, and enteropathy. This study explores the efficacy of Dupilumab (an anti-IL-4Rα monoclonal antibody) in treating persistent, severe dermatitis in an IPEX patient refractory to conventional treatments like sirolimus. We conducted a clinical case study of a 2-year-old IPEX patient with refractory dermatitis. Whole-exome sequencing (WES) confirmed the FOXP3 mutation. Skin biopsies were analyzed for inflammatory gene expression by RNA sequencing and immunohistochemistry to characterize inflammatory pathways. Immune cell phenotyping was performed using flow cytometry pre- and post-treatment in peripheral blood mononuclear cells (PBMCs). The patient was treated with Dupilumab alongside sirolimus and prednisone. Clinical improvements were evaluated using the Eczema Area and Severity Index (EASI) score. Immunohistochemistry revealed elevated IL-13 expression. RNA sequencing of skin samples revealed upregulation of both Th1- and Th2-related genes, suggesting a dual inflammatory phenotype in IPEX dermatitis. The patient exhibited significant clinical improvement after 8 months of sustained Dupilumab therapy, with the EASI decreasing from 24.8 to 0.4. Flow cytometry demonstrated a reduction in Th1 and Th2 cell subsets post-treatment, accompanied by an increase in Treg and Th3 cell populations as well as enhanced expression of immunosuppressive markers such as CTLA-4 and CD39. Dupilumab appears promising as a therapeutic option for managing refractory dermatitis in IPEX, particularly by attenuating Th1/Th2 inflammation and promoting regulatory responses mediated by Treg and Th3 cells. Primary immunodeficiencies are a heterogeneous group of inherited disorders affecting the immune system, with more than 450 distinct genetic defects identified to date. Patients with an X-linked immunodeficiency typically present with frequent and recurrent infections alongside immune dysregulation manifesting as autoimmunity, lymphoproliferation, granuloma formation, chronic inflammatory diseases, and increased susceptibility to malignancies. Among this group of disorders, 7 major X-linked immunodeficiency disorders have been well-characterized: X-linked chronic granulomatous disease (X-CGD), X-linked hyper-IgM syndrome, X-linked lymphoproliferative syndrome (XLP), Wiskott-Aldrich syndrome (WAS), X-linked severe combined immunodeficiency (X-SCID), X-linked agammaglobulinemia (XLA), and IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked) syndrome. These conditions result in cellular or humoral immune deficiency, leading to serious infections and increased morbidity and mortality from early life. Identifying carriers remains challenging in the absence of family history, despite advances in genetic testing.
Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a newly discovered, adult-onset, hemato-inflammatory disease driven by clonal dominance of pro-inflammatory hematopoietic cells bearing a somatic mutation in the UBA1 gene. This review aims to integrate and discuss the most recent insights into the evolving understanding of VEXAS pathogenesis and clinical management. An interplay between inflammation and clonal dominance of UBA1 mutant hematopoietic clones underlies the pathogenesis of VEXAS syndrome. Mutant cells both generate and sustain a toxic inflammatory milieu that impairs wild-type hematopoiesis. Despite exhibiting dysfunctional differentiation, VEXAS cells activate pro-survival pathways that support their persistence and progressive dominance.Recent international guidelines offer evidence-based recommendations to optimize therapy and manage both inflammatory and hematologic features of the disease. This review dissects the key molecular mechanisms driving inflammation and clonal survival in UBA1 mutant cells, and outlines current therapeutic strategies proposed to counteract VEXAS progression and improve patient outcomes. The recent findings presented here, along with the deeper understanding that will be built upon them, not only advance the knowledge of the disease pathobiology, but also pave the way for more precise, mechanism-driven treatment approaches aimed at intercepting disease progression and improving long-term outcomes.
[Immuno'logical (The scientific updates you wouldn't dare to read anywhere else): The hidden face of VEXAS syndrome].
The VEXAS syndrome, whose phenotype has been extensively described in recent years, is now beginning to unveil the secrets of its pathophysiology. For those who tend to keep a respectful distance from basic science papers, Immuno'logical offers a guided dive into two recent fascinating publications, that challenge several long-held assumptions: no, VEXAS is not merely a myeloid disorder; no, UBA1-wild-type cells are not blameless in systemic inflammation; and no, UBA1-mutated progenitors do not owe their clonal dominance to uncontrolled proliferation. To understand it all, we will decode ubiquitination, single-cell RNA-sequencing, and clonal expansion - thoroughly but without unnecessary complexity - to uncover the hidden gems within these studies. In short, let's be serious without taking ourselves too seriously, and explore the hidden side of VEXAS syndrome.
Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.
Autoimmune polyendocrine syndrome (APS) is a clinical disorder characterized by the loss of immune tolerance, leading to dysfunction in multiple endocrine glands. According to the latest disease classification, APS is categorized into three main subtypes: APS-1, APS-2, and IPEX (Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked) syndrome. APS-2 is defined by the presence of at least two autoimmune endocrine disorders, such as type 1 diabetes mellitus, autoimmune thyroiditis, or Addison's disease. APS-2 typically manifests later than APS-1, with onset most commonly occurring in early adulthood. However, pediatric cases involving a combination of autoimmune thyroid disease, type 1 diabetes mellitus, and myasthenia gravis, are extremely rare. This article reported the case of a 3-year-old girl diagnosed with autoimmune polyendocrine syndrome type 2 (APS-2). The patient initially presented with hyperthyroidism and exophthalmos and was subsequently diagnosed with type 1 diabetes mellitus and myasthenia gravis. To our knowledge, this case represents the youngest reported patient of APS-2 at the time of diagnosis, as well as the shortest documented interval between the onset of autoimmune disorders affecting distinct endocrine glands. Through a retrospective analysis, we comprehensively reviewed the phenotypic characteristics of APS-2 and explored its potential immune mechanisms. This article aims to provide clinicians with a valuable reference case to enhance early recognition and facilitate the implementation of targeted prevention and treatment strategies.
Neutrophils take center stage in VEXAS syndrome pathogenesis.
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is an adult-onset inflammatory disorder caused by somatic UBA1 mutations in hematopoietic stem cells. UBA1 encodes a key enzyme that catalyzes protein ubiquitination. Clinically, VEXAS is characterized by systemic inflammation and hematologic abnormalities. Patient studies have hinted that the transition of UBA1-mutated stem cells into proinflammatory myeloid precursors may propagate the manifestations of VEXAS syndrome. In this issue of the JCI, Dong and colleagues developed nine unique conditional knockout mouse strains and found that only neutrophil-specific Uba1 deletion reproduced VEXAS syndrome-like findings. The observed phenotype was at least in part due to inflammatory reprogramming and longer survival of the mutant neutrophils. In addition to deepening our mechanistic understanding of VEXAS syndrome pathogenesis, this work should provide a platform to pursue more targeted approaches to treatment.
Publicações recentes
X-Linked Immunodeficiency.
Atopic dermatitis in inborn errors of immunity: at the interface of immunodeficiency and immune dysregulation.
Case report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.
Diagnostic dilemma in infantile refractory diarrhea: a rare case of IPEX syndrome.
📚 EuropePMC45 artigos no totalmostrando 128
Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.
Journal of clinical immunologyNeutrophils take center stage in VEXAS syndrome pathogenesis.
The Journal of clinical investigationDecoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.
Current opinion in rheumatologyBeyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients.
Journal of clinical immunologyAtopic dermatitis in inborn errors of immunity: at the interface of immunodeficiency and immune dysregulation.
Immunologic researchInterval Changes in Hematopoietic Vacuolization in VEXAS Syndrome with M41T Mutation: Insights into Diagnosis and Disease Progression.
Clinical laboratoryCyclophosphamide post-haploidentical stem cell transplantation experience in an infant with IPEX syndrome.
Biomedica : revista del Instituto Nacional de SaludThe Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients.
Journal of clinical immunologyCase report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Frontiers in immunology[Immuno'logical (The scientific updates you wouldn't dare to read anywhere else): The hidden face of VEXAS syndrome].
La Revue de medecine interneFrom diagnostic uncertainty to targeted therapy: a case-based review of VEXAS syndrome.
Rheumatology internationalClonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.
Expert review of hematologyAutoimmune polyendocrine syndrome type 2 in children: a case report and literature review.
BMC pediatricsDiagnostic dilemma in infantile refractory diarrhea: a rare case of IPEX syndrome.
Medical journal, Armed Forces IndiaVEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management.
Annals of hematologySirolimus alleviated intractable diarrhea of IPEX syndrome: a case report and literature review.
BMC pediatricsExpanding the spectrum of IPEX: from new clinical findings to novel treatments.
Current opinion in allergy and clinical immunologyDiverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey.
Journal of clinical immunologyHSCT in a Patient with Cernunnos/XLF Deficiency and Omenn Syndrome.
Journal of clinical immunologyA rare case of late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome confused with IgA vasculitis nephropathy.
Pediatric nephrology (Berlin, Germany)A splice of life: the discovery, function, and clinical implications of FOXP3 isoforms in autoimmune disease.
International immunologyIL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10.
Journal of immunology (Baltimore, Md. : 1950)Effective Management of XLA Associated Enteropathy with Vedolizumab Monotherapy.
Journal of clinical immunologySalvianolic acid B alleviates autoimmunity in Treg-deficient mice via inhibiting IL2-STAT5 signaling.
Phytotherapy research : PTRNovel premature termination codon in the FOXP3 gene as the cause of familial hydrops fetalis in males.
Prenatal diagnosis[Clinical features and genetic analysis of three patients with Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome due to variants of FOXP3 gene].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsIPEX syndrome from diagnosis to cure, learning along the way.
The Journal of allergy and clinical immunologyA novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products.
Molecular therapy. Methods & clinical developmentFOXP3 deficiency, from the mechanisms of the disease to curative strategies.
Immunological reviews[Hematopoietic cell transplantation for monogenic inflammatory bowel disease].
[Rinsho ketsueki] The Japanese journal of clinical hematologyMutations from patients with IPEX ported to mice reveal different patterns of FoxP3 and Treg dysfunction.
Cell reportsRegulatory T cells in peripheral tissue tolerance and diseases.
Frontiers in immunologyA Case Report of IPEX Syndrome with Neonatal Diabetes Mellitus and Congenital Hypothyroidism as the Initial Presentation, and a Systematic Review of neonatal IPEX.
Journal of clinical immunologyCase report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis.
Frontiers in immunologyFOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome.
Journal of clinical immunologyCase Report: Eosinophilic gastritis with pyloric stenosis in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Frontiers in pediatricsSplicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.
Molecular immunologyImmune dysregulation, polyendocrinopathy and enteropathy, X-linked (IPEX) syndrome due to a mutation in FOXP3, modified by a pathogenic variant in SON (SON DNA-binding protein).
Journal of applied geneticsEpigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation.
The Journal of allergy and clinical immunologyAtopic Dermatitis-like Genodermatosis: Disease Diagnosis and Management.
Diagnostics (Basel, Switzerland)Clinical and immunological characteristics of five patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China-expanding the atypical phenotypes.
Frontiers in immunologyTowards gene therapy for IPEX syndrome.
European journal of immunologyIdentification of a novel variant of FOXP3 resulting in severe immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome highlights potential pitfalls of molecular testing.
Pediatric dermatologyProtein-losing enteropathy caused by Yersinia enterocolitica colitis.
Paediatrics and international child healthAnti-voltage-Gated Potassium Channel (VGKC) Antibodies and Acquired Neuromyotonia in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy X-Lined (IPEX) Syndrome.
Journal of clinical immunologyGeneralized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
Pediatric dermatologyMyelodysplastic Syndrome in a Patient with IPEX Syndrome.
Journal of clinical immunologyImmune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Manifesting as Lymphocytic Interstitial Pneumonia and Treatment-Resistant Bullous Pemphigoid.
Pediatric allergy, immunology, and pulmonologyImmune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome in Two Siblings: Same Mutation But Different Clinical Manifestations at Onset.
Journal of clinical research in pediatric endocrinologyMolecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management.
The Journal of allergy and clinical immunologySingle-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4+ T cell perturbations.
Nature immunologyLimosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg deficiency.
American journal of physiology. Gastrointestinal and liver physiologyA delayed diagnosis of atypical immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A case report.
Medicine[Clinical features and genetic analysis of a child with late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-Linked syndrome].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsNew Findings of Immunodysregulation, Polyendocrinopathy, and Enteropathy X-linked Syndrome (IPEX); Granulomas in Lung and Duodenum.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyIPEX Syndrome: Genetics and Treatment Options.
GenesA hemizygous mutation in the FOXP3 gene (IPEX syndrome) resulting in recurrent X-linked fetal hydrops: a case report.
BMC medical genomicsAtypical late-onset severe gastritis in immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome: 2 case reports.
Medicine[New mutation in FOXP3 gene identified in an infant with chronic diarrhea as manifestation of autoinmune enteropathy - IPEX syndrome].
Revista chilena de pediatriaFecal microbiota transplantation before hematopoietic stem cell transplantation in a pediatric case of chronic diarrhea with a FOXP3 mutation.
Pediatrics and neonatologyT cell gene therapy to treat immunodeficiency.
British journal of haematologyOpinion and Special Articles: Cerebellar Ataxia and Liver Failure Complicating IPEX Syndrome.
NeurologyPosthematopoietic stem cell transplant COVID-19 infection in a pediatric patient with IPEX syndrome.
Pediatric blood & cancerIPEX Syndrome with Normal FOXP3 Protein Expression in Treg Cells in an Infant Presenting with Intractable Diarrhea as a Single Symptom.
Case reports in immunologyFungal infections in primary immunodeficiency diseases.
Clinical immunology (Orlando, Fla.)Foxp3: a genetic foundation for regulatory T cell differentiation and function.
Nature immunologyEarly-onset refractory diarrhea due to immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with a novel mutation in the FOXP3 gene: A case report.
World journal of clinical casesIn situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice.
Nature communicationsInfliximab induces clinical resolution of sacroiliitis that coincides with increased circulating FOXP3+ T cells in a patient with IPEX syndrome.
Joint bone spinePharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.
Frontiers in immunologyMolecular feature and therapeutic perspectives of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Journal of genetics and genomics = Yi chuan xue baoUnusual and early onset IPEX syndrome: a case report.
The Turkish journal of pediatricsIPEX syndrome: an easily-missed diagnosis of a life threatening condition.
The Turkish journal of pediatricsTreatment with rapamycin can restore regulatory T-cell function in IPEX patients.
The Journal of allergy and clinical immunologyGermline gain-of-function mutation of STAT1 rescued by somatic mosaicism in immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like disorder.
The Journal of allergy and clinical immunologyAntibiotic-modulated microbiome suppresses lethal inflammation and prolongs lifespan in Treg-deficient mice.
MicrobiomeHematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome.
Pediatric diabetes[A case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome with very early onset inflammatory bowel disease-like changes].
Zhonghua er ke za zhi = Chinese journal of pediatrics[Erythroderma revealing IPEX syndrome].
Annales de dermatologie et de venereologieThe autoimmune targets in IPEX are dominated by gut epithelial proteins.
The Journal of allergy and clinical immunologyIdentification of autoantibodies using human proteome microarrays in patients with IPEX syndrome.
Clinical immunology (Orlando, Fla.)The FOXP3Δ2 isoform supports Treg cell development and protects against severe IPEX syndrome.
The Journal of allergy and clinical immunologyMechanisms of human FoxP3+ Treg cell development and function in health and disease.
Clinical and experimental immunologyThe role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases.
Clinical and experimental immunologyRecurrent Non Immune Fetal Hydrops Associated With IPEX Syndrome.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyImmune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Associated With a Novel Mutation of FOXP3 Gene.
Frontiers in pediatricsA Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells.
ImmunityLentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome.
Cell stem cellClinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study.
Clinical and translational gastroenterologyHypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome.
Clinical immunology (Orlando, Fla.)Regulatory T-cell deficiency and autoimmune skin disease: Beyond the scurfy mouse and immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
The Journal of allergy and clinical immunology[Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in two cases].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsRole of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis.
The Journal of allergy and clinical immunologyRegulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects.
The Journal of allergy and clinical immunologyIPEX due to an exon 7 skipping FOXP3 mutation with autoimmune diabetes mellitus cured by selective TReg cell engraftment.
Clinical immunology (Orlando, Fla.)Autoimmune Polyendocrine Syndromes.
The New England journal of medicineSomatic and germline FOXP3 mosaicism in the mother of a boy with IPEX syndrome.
European journal of immunologyAtypical Late-Onset Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome with Intractable Diarrhea: A Case Report.
Frontiers in pediatricsLong-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.
The Journal of allergy and clinical immunologyFOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Pediatric diabetesDOCK8 Deficiency Presenting as an IPEX-Like Disorder.
Journal of clinical immunologyPrenatal Bowel Findings in Male Siblings With a Confirmed FOXP3 Mutation.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in MedicineCurcumin attenuates the scurfy-induced immune disorder, a model of IPEX syndrome, with inhibiting Th1/Th2/Th17 responses in mice.
Phytomedicine : international journal of phytotherapy and phytopharmacologyWhole genome sequencing identifies etiology of recurrent male intrauterine fetal death.
Prenatal diagnosisAnalyses of a Mutant Foxp3 Allele Reveal BATF as a Critical Transcription Factor in the Differentiation and Accumulation of Tissue Regulatory T Cells.
ImmunityLichenoid Dermatitis in an Adult with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.
SkinmedPLA2R-positive (primary) membranous nephropathy in a child with IPEX syndrome.
Pediatric nephrology (Berlin, Germany)Persistent Enteropathy in a Toddler with a Novel FOXP3 Mutation and Normal FOXP3 Protein Expression.
The Journal of pediatricsNovel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound.
American journal of medical genetics. Part AThe plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency.
Turk pediatri arsiviMycobacterium genavense-induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature.
Transplant infectious disease : an official journal of the Transplantation SocietyNonclassic Inflammatory Bowel Disease in Young Infants: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome, and Other Disorders.
Pediatric clinics of North AmericaExtremely Early Onset IPEX Syndrome Caused by a Novel Small Exonic Deletion in FOXP3.
Journal of pediatric gastroenterology and nutritionDeficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome.
Journal of pediatric gastroenterology and nutritionT Regulatory Cell Biology in Health and Disease.
Current allergy and asthma reportsFrom IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation.
Annals of the New York Academy of SciencesQuantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature.
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhiClinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome.
Clinical immunology (Orlando, Fla.)Immune Dysregulation Syndromes (IPEX, CD27 Deficiency, and Others): Always Doomed from the Start?
Journal of clinical immunologyA challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
The Journal of allergy and clinical immunologyThe autoimmune conundrum in common variable immunodeficiency disorders.
Current opinion in allergy and clinical immunologyThe immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Current opinion in allergy and clinical immunologyIdentification of a novel nonsense mutation in the FOXP3 gene in a fetus with hydrops--Expanding the phenotype of IPEX syndrome.
American journal of medical genetics. Part A[Difference in target antigens between central tolerance and peripheral tolerance deficiencies].
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunologyImmune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and recurrent intrauterine fetal death.
Lancet (London, England)Long-term disease course in a patient with severe neonatal IPEX syndrome.
Clinics and research in hepatology and gastroenterologyImmune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita.
Pediatric dermatologyFamilial IPEX syndrome: different glomerulopathy in two siblings.
Pediatrics international : official journal of the Japan Pediatric SocietyAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.
- Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.
- [Immuno'logical (The scientific updates you wouldn't dare to read anywhere else): The hidden face of VEXAS syndrome].
- Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.
- Neutrophils take center stage in VEXAS syndrome pathogenesis.
- X-Linked Immunodeficiency.
- Atopic dermatitis in inborn errors of immunity: at the interface of immunodeficiency and immune dysregulation.
- Case report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
- Diagnostic dilemma in infantile refractory diarrhea: a rare case of IPEX syndrome.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:37042(Orphanet)
- OMIM OMIM:304790(OMIM)
- MONDO:0010580(MONDO)
- GARD:1850(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q3508566(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
